A carregar...
Peginesatide for the treatment of anemia due to chronic kidney disease – an unfulfilled promise
INTRODUCTION: The introduction of recombinant human erythropoietin revolutionized the management of anemia in patients with chronic kidney disease (CKD). In order to circumvent costly recombinant DNA technology, synthetic chemistry techniques were used to manufacture peginesatide, a synthetic peptid...
Na minha lista:
| Publicado no: | Expert Opin Drug Saf |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5286458/ https://ncbi.nlm.nih.gov/pubmed/27551882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14740338.2016.1218467 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|